Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Catheter Precision, Inc. (VTAK : AMEX)
 
 • Company Description   
Catheter Precision Inc. is a medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. Catheter Precision Inc., formerly known as Ra Medical Systems Inc., is based in FORT MILL, SC.

Number of Employees: 22

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.24 Daily Weekly Monthly
20 Day Moving Average: 1,559,093 shares
Shares Outstanding: 11.02 (millions)
Market Capitalization: $2.66 (millions)
Beta: -0.72
52 Week High: $4.10
52 Week Low: $0.16
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -33.81% -36.80%
12 Week -24.48% -36.26%
Year To Date -46.43% -49.67%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1670 Highway 160 West Suite 205
-
Fort Mill,SC 29708
USA
ph: 973-691-2000
fax: -
ir@catheterprecision.com http://www.catheterprecision.com
 
 • General Corporate Information   
Officers
David A. Jenkins - Executive Chairman and Chief Executive Officer
Philip Anderson - Chief Financial Officer
James Caruso - Director
Martin Colombatto - Director
Andrew Arno - Director

Peer Information
Catheter Precision, Inc. (ABMD)
Catheter Precision, Inc. (DMDS)
Catheter Precision, Inc. (CPWY.)
Catheter Precision, Inc. (EQUR)
Catheter Precision, Inc. (ECIA)
Catheter Precision, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 74933X609
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/13/25
Share - Related Items
Shares Outstanding: 11.02
Most Recent Split Date: 7.00 (0.10:1)
Beta: -0.72
Market Capitalization: $2.66 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-6.30 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.28
Price/Cash Flow: -
Price / Sales: 5.53
EPS Growth
vs. Year Ago Period: 90.00%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: 74.39%
vs. Previous Quarter: -4.03%
ROE
06/30/25 - -
03/31/25 - -153.90
12/31/24 - -115.93
ROA
06/30/25 - -
03/31/25 - -68.25
12/31/24 - -61.19
Current Ratio
06/30/25 - -
03/31/25 - 0.21
12/31/24 - 1.58
Quick Ratio
06/30/25 - -
03/31/25 - 0.19
12/31/24 - 1.56
Operating Margin
06/30/25 - -
03/31/25 - -3,744.91
12/31/24 - -3,962.62
Net Margin
06/30/25 - -
03/31/25 - -3,744.91
12/31/24 - -3,962.62
Pre-Tax Margin
06/30/25 - -
03/31/25 - -3,242.41
12/31/24 - -3,214.76
Book Value
06/30/25 - -
03/31/25 - 0.85
12/31/24 - 1.33
Inventory Turnover
06/30/25 - -
03/31/25 - 0.96
12/31/24 - 0.88
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.13
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 11.31
 

Powered by Zacks Investment Research ©